Amanda Woerman, PhD, Prion Research Center, Colorado State University, Fort Collins, CO
Brian Appleby, MD, Director, National Prion Disease Pathology Surveillance Center, Case Western Reserve University, Cleveland, OH
Byron Caughey, PhD, Rocky Mountain Labs, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT
Christina Sigurdson, DVM, PhD, University of Califonia, Davis and University of California, San Diego, San Diego, CA
Claudio Soto, PhD, Director, The George and Cynthia W Mitchell Center for Alzheimer's Disease and Other Brain Related Illnesses, University of Texas, Houston, TX
Debbie Yobs, President and Executive Director, CJD Foundation
Gabor Kovacs, MD, PhD, Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada
Glenn Telling, PhD, Director, Prion Research Center, Colorado State University, Fort Collins, CO
Joel Watts, PhD, Associate Professor, Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada
Richard Knight, BA, BM BCh, FRCP(E), Chair, CJD Support Network, U.K. and Emeritus Professor of Clinical Neurology, The University of Edinburgh, Edinburgh, Scotland
Simon Mead, PhD, Clinical Professor, MRC Prion Unit at UC London, Institute of Prion Diseases, London, England
Sonia Vallabh, PhD, Senior Group Leader, Broad Institute, Cambridge, MA